3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Other
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
90
Leukemia
45
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
12
Burkitt Lymphoma
12
Leukemia, Biphenotypic, Acute
9
Recurrence
8
Lymphoma
8
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia, T-Cell
4
Leukemia, Myeloid, Acute
3
Neoplasms
2
Neoplasm, Residual
2
Lymphoma, T-Cell
2
Down Syndrome
2
Mucositis
1
Lymphoproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphoid
1
Leukemia, B-Cell
1
Immunoproliferative Disorders
1
Hematologic Neoplasms
1
Drug-Related Side Effects and Adverse Reactions
1
Blast Crisis
1
Interventions
angiotensin I (1-7)
4
pegaspargase
1
nelarabine
1
fludarabine phosphate
1
Whole-Body Irradiation
1
Vincristine
1
Rituximab
1
Radiotherapy
1
Quercetin
1
Passive Cutaneous Anaphylaxis
1
Morphine
1
Methotrexate
1
Methadone
1
Mercaptopurine
1
Melphalan
1
Laser Therapy
1
Imatinib Mesylate
1
Hydromorphone
1
Gelclair
1
Fibroblast Growth Factor 7
1
Etoposide
1
Drug Therapy
1
Daunorubicin
1
Cytarabine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mucositis
×
pegaspargase
×
Other hematologic neoplasm
×
Clear all
NCT01085617
2025-03-30
UKALL14
University College, London
Completed